The discontinuation of several insulin products will leave many patients struggling to adjust to new medicine strengths and devices.

New Pharmaceutical Benefits Advisory Committee (PBAC) recommendations could significantly change who can access funded COVID-19 and RSV vaccines. At its December 2025 meeting, PBAC considered...

This week pharmacists will see a suite of regulatory and funding changes take effect. Here are the six key updates pharmacists need to know before...

All incidents should be reported, no matter how minor. Here’s how pharmacists can best approach this process.

The Australian Health Practitioner Regulation Agency (AHPRA) has cracked down on medicinal cannabis, with new guidance to tighten up the rules and put practitioners...

Working on a new mechanism of action, this treatment could change the lives of patients with schizophrenia. But not all patients can take it.